Tyrosinemia Type I and Reversible Neurogenic Crisis After a One-Month Interruption of Nitisinone
Hereditary tyrosinemia Type I (HTI) is an autosomal recessive disorder due to a deficiency of the enzyme fumarylacetoacetate hydrolase. The liver is the primary organ that is affected and comorbidities with renal and neurologic systems and hepatocellular carcinoma can be seen as a long-term complica...
Main Authors: | Havva Yazıcı, Ebru Canda, Esra Er, Mehmet Arda Kılınç, Sema Kalkan Uçar, Bülent Karapınar, Mahmut Çoker |
---|---|
Format: | Article |
Language: | English |
Published: |
Galenos Yayinevi
2018-03-01
|
Series: | Journal of Pediatric Research |
Subjects: | |
Online Access: |
http://jpedres.org/archives/archive-detail/article-preview/tyrosinemia-type--and-reversible-neurogenic-crisis/18786
|
Similar Items
-
Clinical Features of 29 Patients with Hereditary Tyrosinemia I in Western Turkey
by: Havva Yazıcı, et al.
Published: (2018-03-01) -
Cardiomyopathy in patients with type 1 tyrosinemia, and the effect of nitisinone treatment on cardiomyopathy
by: Berrak Bilginer Gürbüz, et al.
Published: (2021-12-01) -
Hereditary Tyrosinemia Type 1 Mice under Continuous Nitisinone Treatment Display Remnants of an Uncorrected Liver Disease Phenotype
by: Jessie Neuckermans, et al.
Published: (2023-03-01) -
Oxidative Stress, Glutathione Metabolism, and Liver Regeneration Pathways Are Activated in Hereditary Tyrosinemia Type 1 Mice upon Short-Term Nitisinone Discontinuation
by: Haaike Colemonts-Vroninks, et al.
Published: (2020-12-01) -
Tyrosinemia type I: an unusual case presentation
by: Marwa ALMahroos, et al.
Published: (2022-06-01)